Abstract

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Ludew D, Wertheim-Tysarowska K, Budnik K, Grabarczyk A, Kowalewski C, Kapińska-Mrowiecka M. Lipoid proteinosis: a first report of mutation Val10Gly in the signal peptide of the ECM1 gene. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2018;35(2):208-211. doi:10.5114/ada.2018.75245. APA Ludew, D., Wertheim-Tysarowska, K., Budnik, K., Grabarczyk, A., Kowalewski, C., & Kapińska-Mrowiecka, M. (2018). Lipoid proteinosis: a first report of mutation Val10Gly in the signal peptide of the ECM1 gene. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 35(2), 208-211. https://doi.org/10.5114/ada.2018.75245 Chicago Ludew, Dominik, Katarzyna Wertheim-Tysarowska, Katarzyna Budnik, Alicja Grabarczyk, Cezary Kowalewski, and Monika Kapińska-Mrowiecka. 2018. "Lipoid proteinosis: a first report of mutation Val10Gly in the signal peptide of the ECM1 gene". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 35 (2): 208-211. doi:10.5114/ada.2018.75245. Harvard Ludew, D., Wertheim-Tysarowska, K., Budnik, K., Grabarczyk, A., Kowalewski, C., and Kapińska-Mrowiecka, M. (2018). Lipoid proteinosis: a first report of mutation Val10Gly in the signal peptide of the ECM1 gene. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 35(2), pp.208-211. https://doi.org/10.5114/ada.2018.75245 MLA Ludew, Dominik et al. "Lipoid proteinosis: a first report of mutation Val10Gly in the signal peptide of the ECM1 gene." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 35, no. 2, 2018, pp. 208-211. doi:10.5114/ada.2018.75245. Vancouver Ludew D, Wertheim-Tysarowska K, Budnik K, Grabarczyk A, Kowalewski C, Kapińska-Mrowiecka M. Lipoid proteinosis: a first report of mutation Val10Gly in the signal peptide of the ECM1 gene. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2018;35(2):208-211. doi:10.5114/ada.2018.75245.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.